Form D · Other Health Care
Spinogenix, Inc.
Los Angeles, CA · CIK 0001718198
Offering snapshot reported Mar 9, 2026 · SEC filing
- Reported sold
- $10.6M Offering amount: $35M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 21, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 9, 2026 | Initial | $10,606,566 | No comparison | 5 | SEC filing |
| Jun 21, 2024 | Initial | $2,800,000 | No comparison | 3 | SEC filing |
| Aug 10, 2023 | Initial | $5,199,985 | No comparison | 3 | SEC filing |
| Sep 13, 2022 | Amendment | $3,335,431 | $0vs Sep 12, 2022 | 3 | SEC filing |
| Sep 12, 2022 | Initial | $3,335,431 | No comparison | 3 | SEC filing |
| Feb 24, 2021 | Initial | $1,557,403 | No comparison | 22 | SEC filing |
| Sep 17, 2020 | Initial | $250,000 | No comparison | 12 | SEC filing |
| May 7, 2018 | Amendment | $903,335 | $803,335vs Oct 4, 2017 | 10 | SEC filing |
| Oct 4, 2017 | Initial | $100,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-575854
Source: Form D, filed Mar 9, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dan Albosta | Executive |
| Franz Hefti | Director |
| Stella Sarraf | Director, Executive |
| Stella Sarraf, Ph.D. | Director, Executive |
| Vincent Simmon | Director, Executive |
| Jerre Stead | Director |
| Jerre L. Stead | Director |
| Josh Swartz | Director |
| Mervyn Turner | Director |
| Mervyn Turner, Ph.D. | Director |
| Peter Whitney Vanderklish | Executive |
| Steve Young | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1801 Century Park East, Suite 2400
Los Angeles, CA, 90067
Los Angeles, CA, 90067